UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients

Oncoimmunology, 2016-12, Vol.5 (12), p.e1255394-e1255394

2016

Volltextzugriff (PDF)

TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma

Clinical cancer research, 2018-11, Vol.24 (22), p.5710-5723

2018

Volltextzugriff (PDF)

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

Journal of translational medicine, 2019-11, Vol.17 (1), p.357-357, Article 357

2019

Volltextzugriff (PDF)

Origins of rheumatoid arthritis

Joint, bone, spine : revue du rhumatisme, 2020-07, Vol.87 (4), p.301-306

2020

Volltextzugriff (PDF)

Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2020-04, Vol.72 (4), p.576-587

2020

Volltextzugriff (PDF)

Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients

Frontiers in immunology, 2021-03, Vol.12, p.626776-626776

2021

Volltextzugriff (PDF)

Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.844-856

2019

Volltextzugriff (PDF)

SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils

Lung cancer (Amsterdam, Netherlands), 2022-07, Vol.169, p.13-21

2022

Volltextzugriff (PDF)

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome

Oncoimmunology, 2018-01, Vol.7 (5), p.e1423184-e1423184

2018

Volltextzugriff (PDF)

Le concept de l’exposome appliqué à la polyarthrite rhumatoïde

Revue du rhumatisme (Ed. française : 1993), 2023-03, Vol.90 (2), p.150-158

2023

Volltextzugriff (PDF)

Response to Comment on “Interplay between TNF and Regulatory T Cells in a TNF-Driven Murine Model of Arthritis”

The Journal of immunology (1950), 2011-08, Vol.187 (4), p.1527-1528

2011

Volltextzugriff (PDF)

Abstract 573: Mutations found by targeted next generation sequencing is associated with intra-tumor immune profile and may predict response to anti-PD1 therapy in lung adenocarcinoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.573-573

2019

Volltextzugriff (PDF)

Abstract 4546: The tumor inflammation signature is predictive of anti-PD1 treatment benefit in the CERTIM pan-cancer cohort

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4546-4546

2018

Volltextzugriff (PDF)

A3.10 IL-6 Receptor Blockade Enhances CD39+ Regulatory T-Cell Development in Rheumatoid Arthritis and in Experimental Arthritis

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A16-A17

2013

Volltextzugriff (PDF)

A3.10IL-6 Receptor Blockade Enhances CD39+ Regulatory T-Cell Development in Rheumatoid Arthritis and in Experimental Arthritis

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A16-A17

2013

Volltextzugriff (PDF)

L’origine de la polyarthrite rhumatoïde

Revue du rhumatisme (Ed. française : 1993), 2019-11, Vol.86, p.A19-A24

2019

Volltextzugriff (PDF)

La pollution atmosphérique comme facteur déterminant de la polyarthrite rhumatoïde

Revue du rhumatisme (Ed. française : 1993), 2018-12, Vol.85 (6), p.529-535

2018

Volltextzugriff (PDF)

1.64 Interleukin-33 suppresses experimental arthritis through promoting Foxp3+ regulatory T-cells and type-2 immune responses in mice

Annals of the rheumatic diseases, 2014-03, Vol.73 (Suppl 1), p.A28-A28

2014

Volltextzugriff (PDF)

Combination of active and passive anti-TNFα treatments in human-TNFα transgenic mice

Annals of the rheumatic diseases, 2011-03, Vol.70 (Suppl 2), p.A70

2011

Volltextzugriff (PDF)

Combination of active and passive anti-TNF treatments in human-TNF transgenic mice

Annals of the rheumatic diseases, 2011-03, Vol.70 (Suppl 2), p.A70-A70

2011

Volltextzugriff (PDF)

Le TNF-α : activateur ou inhibiteur des cellules T régulatrices ?

Revue du rhumatisme (Ed. française : 1993), 2011-12, Vol.78 (6), p.519-524

2011

Volltextzugriff (PDF)

Les cellules T régulatrices (Treg) dans la polyarthrite rhumatoïde

Revue du rhumatisme (Ed. française : 1993), 2009-01, Vol.76 (1), p.10-15

2009

Volltextzugriff (PDF)

Rufinamide

The Treatment of Epilepsy, 2015, p.617-627

2015

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)
Buchkapitel
(2)

Sprache

Englisch
(21)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients

TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti-PD-1 in Lung Adenocarcinoma

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

Origins of rheumatoid arthritis

Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis

Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients

Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors

The New Histologic Classification of Lung Primary Adenocarcinoma Subtypes Is a Reliable Prognostic Marker and Identifies Tumors With Different Mutation Status

SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome

Le concept de l’exposome appliqué à la polyarthrite rhumatoïde

Response to Comment on “Interplay between TNF and Regulatory T Cells in a TNF-Driven Murine Model of Arthritis”

Abstract 573: Mutations found by targeted next generation sequencing is associated with intra-tumor immune profile and may predict response to anti-PD1 therapy in lung adenocarcinoma

Abstract 4546: The tumor inflammation signature is predictive of anti-PD1 treatment benefit in the CERTIM pan-cancer cohort

A3.10 IL-6 Receptor Blockade Enhances CD39+ Regulatory T-Cell Development in Rheumatoid Arthritis and in Experimental Arthritis

A3.10IL-6 Receptor Blockade Enhances CD39+ Regulatory T-Cell Development in Rheumatoid Arthritis and in Experimental Arthritis

L’origine de la polyarthrite rhumatoïde

La pollution atmosphérique comme facteur déterminant de la polyarthrite rhumatoïde

1.64 Interleukin-33 suppresses experimental arthritis through promoting Foxp3+ regulatory T-cells and type-2 immune responses in mice

Combination of active and passive anti-TNFα treatments in human-TNFα transgenic mice

Combination of active and passive anti-TNF treatments in human-TNF transgenic mice

Le TNF-α : activateur ou inhibiteur des cellules T régulatrices ?

Les cellules T régulatrices (Treg) dans la polyarthrite rhumatoïde

SMARCA4-Deficient Lung Carcinoma is an Aggressive Tumor Highly Infiltrated by FOXP3+ Cells and Neutrophils

Rufinamide

Aktive Filter

Suchergebnisse filtern